BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23083609)

  • 21. Mammographic screening for breast cancer: An invited review of the benefits and costs.
    Greif JM
    Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cost-effectiveness analysis of preoperative MR mammography in suspect breast lesions].
    Schneider A; Malur S; Hartmann M
    Rofo; 2002 Apr; 174(4):501; author reply 501-2. PubMed ID: 11960419
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
    Olivotto IA; Kan L; Mates D; King S
    CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fibrotic focus in MR-mammography.
    Van Goethem M; Hufkens G; Verslegers I; Van Marck V; Biltjes I; Parizel PM
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S179-80. PubMed ID: 23083581
    [No Abstract]   [Full Text] [Related]  

  • 25. Summaries for patients. Screening for breast cancer: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2009 Nov; 151(10):I44. PubMed ID: 19920254
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy--monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?
    Schulz-Wendtland R
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S147-8. PubMed ID: 23083568
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mammography screening. Senselessly squandered money?].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Mar; 142(12):4-8. PubMed ID: 10804710
    [No Abstract]   [Full Text] [Related]  

  • 29. Costs of different follow-up strategies in early breast cancer: a review of the literature.
    van Hezewijk M; van den Akker ME; van de Velde CJ; Scholten AN; Hille ET
    Breast; 2012 Dec; 21(6):693-700. PubMed ID: 23084960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stopping the drain of dollars spent on breast cancer.
    Kneece J
    Adm Radiol; 1994 Jun; 13(6):27-9. PubMed ID: 10136526
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings.
    Kirchhoff T; Ruof J; Mittendorf T; Rihl M; Bernateck M; Mau W; Zeidler H; Schmidt RE; Merkesdal S
    Rheumatology (Oxford); 2011 Apr; 50(4):756-61. PubMed ID: 21149243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast MR imaging. An analysis of its role with respect to other imaging and interventional modalities.
    Brenner RJ
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):705-23. PubMed ID: 7489318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing costs and benefits of mammography screening in the workplace.
    Eley JW
    AAOHN J; 1989 May; 37(5):171-7. PubMed ID: 2496692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology assessment: a perspective from the National Cancer Institute.
    Shtern F
    Acad Radiol; 1996 Apr; 3 Suppl 1():S84-7. PubMed ID: 8796524
    [No Abstract]   [Full Text] [Related]  

  • 38. Can we use MR-mammography to predict nodal status?
    Carbonaro LA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S17-8. PubMed ID: 23083577
    [No Abstract]   [Full Text] [Related]  

  • 39. Breast cancer screening and problem solving using mammography, ultrasound, and magnetic resonance imaging.
    Hooley RJ; Andrejeva L; Scoutt LM
    Ultrasound Q; 2011 Mar; 27(1):23-47. PubMed ID: 21343800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
    Burnside E; Belkora J; Esserman L
    Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.